implementation; and the involvement of other U.S. agencies seems appropriate. It is not yet clear how such collaboration might progress in the absence of the International Science and Technology Center (ISTC) to facilitate program management and accounting or where funding might originate.
Over the years, the following Russian institutes have been the principal partners of CDC:
State Research Center of Virology and Biotechnology Vector
State Research Center for Applied Microbiology
Central Institute of Epidemiology
Mechnikov Institute of Vaccines and Sera
Research Institute of Influenza
Sustaining advances that have been made will depend upon access to limited funds to allow continued scientist-to-scientist dialogue and technical exchanges coupled with more significant investments in major projects that can be undertaken in true partnership, including shared costs and personnel commitments divided by the two sides. Collaborative projects between CDC and Russian partners have relied on the ISTC to facilitate program management and to handle financial resources. The ISTC consistently played a critical role in this regard and has been part of the basic infrastructure required for the program’s success. With changes in management procedures on the U.S. side and the closure of the ISTC in Russia, there are significant hurdles to be overcome in moving resources between countries and distribution and accounting procedures if a similar model of collaboration is to continue in the future.
Of special significance for future activities is the Protocol of Intent between CDC and the Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being to Combat Communicable and Non-Communicable Diseases, signed in 2012 for an indefinite duration.
SOURCE: Information provided by CDC, November 2011 and May 2012, and by committee members.